Skip to content

GORE VIABAHN VBX Balloon Expandable Endo BXB077902ARecalls & reported problems

W. L. Gore & Associates, Inc. · BX2 HEP REDUCED PROFILE BX2 7MMX79MM 6Fr 135CM Cath · Class 3 · Implant

All models of GORE VIABAHN VBX Balloon Expandable Endo (111)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
8
Deaths reported
0
Injuries reported
8
Recalls naming it
1

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00733132658688), received between Nov 4, 2025 and Sep 30, 2026 — classified as 8 injuries.

The most frequently reported specific device problem is “Complete Blockage” (2 reports).

1 FDA recall record name this device's identifier, 1 still open.

1 other recall cover devices cleared under the same FDA submission (P160021); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 2 reportsMar 2026: 1 reportsApr 2026: 2 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jul 1, 2024Class IIOpen, Classified

    Due to packaging defects, sterility assurance and heparin activity may be compromised.

    Z-2945-2024 · Root cause: Package design/selection · Recall details · FDA record ↗

Most reported problems

Device problems

  • Complete Blockage2
  • Partial Blockage2
  • Activation Failure1
  • Adverse Event Without Identified Device or Use Problem1
  • Deformation Due to Compressive Stress1
  • Device Damaged by Another Device1
  • Device Dislodged or Dislocated1
  • Device Endoleak1

Patient problems

  • Stenosis4
  • Clinical Endoleak2
  • Reduced Blood Flow2
  • Thrombosis/Thrombus2
  • Obstruction/Occlusion1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • InjurySep 30, 2026Complete Blockage

    Patient problems: Obstruction/Occlusion; Stenosis

    MAUDE report 50955046 ↗
  • InjuryJun 8, 2026Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2025, THE PATIENT UNDERWENT ENDOVASCULAR PROCEDURE TO TREAT A THORACOABDOMINAL AORTIC ANEURYSM OF THE DESCENDING THORACIC AORTA. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS DEVICES WERE USED IN THE VISCERAL ARTERIES. THE PATIENT TOLERATED THE PROCEDURE. THE GORE DEVICES WERE SUCCESSFULLY IMPLANTED. ON (B)(6) 2025, THE PATIENT WAS DISCHARGED HOME. ON (B)(6) 2025, FOLLOW UP CTA IMAGING SHOWED LEFT RENAL SIDE BRANCH STENT STENOSIS (> 75%). ON (B)(6) 2025, AN ENDOVASCULAR REINTERVENTION PROCEDURE WAS PERFORMED FOR LEFT RENAL ARTERY STENT STENOSIS. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY WAS PERFORMED AND AN 8 MM X 59 MM OMNILINK ELITE VASCULAR BALLOON-EXPANDABLE STENT WAS IMPLANTED.

    Patient problems: Reduced Blood Flow; Stenosis

    MAUDE report 25437532 ↗
  • InjuryApr 16, 2026Complete Blockage

    THE FOLLOWING INFORMATION WAS REPORTED THROUGH THE AAA 24-01 TAMBE POST APPROVAL STUDY: ON (B)(6) 2026, THE PATIENT UNDERWENT ENDOVASCULAR PROCEDURE TO TREAT A THORACOABDOMINAL AORTIC ANEURYSM USING A GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS (TAMBE) DEVICE SYSTEM AND GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX DEVICE). DURING THE INDEX PROCEDURE THE RIGHT RENAL ARTERY WAS COIL EMBOLIZED. ON (B)(6) 2026, RIGHT RENAL INFARCT WAS IDENTIFIED.

    Patient problems: Stenosis

    MAUDE report 24905048 ↗
  • InjuryApr 3, 2026Partial Blockage

    THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6), 2025, THE PATIENT UNDERWENT ENDOVASCULAR PROCEDURE TO TREAT A THORACOABDOMINAL AORTIC ANEURYSM USING A GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS (TAMBE) DEVICE SYSTEM. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX DEVICES) WERE IMPLANTED WITH THE TAMBE DEVICE. ON AN UNKNOWN DATE, THE RIGHT RENAL ARTERY THROMBOSED POST PROCEDURE AND A REINTERVENTION WAS PERFORMED PLACING A GORE® VIABAHN® ENDOPROSTHESIS (VSX DEVICE) DISTALLY IN THE RENAL ARTERY TO TREAT THE OCCLUSION. THE PATIENT DID NOT EXPERIENCE ANY ADVERSE CONSEQUENCES.

    Patient problems: Stenosis

    MAUDE report 24782285 ↗
  • InjuryMar 30, 2026Deformation Due to Compressive Stress; Device Damaged by Another Device

    THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2026, A PATIENT UNDERWENT A GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS (TAMBE) PROCEDURE. DURING THIS PROCEDURE, THE LEFT RENAL ARTERY (LRA) WAS NOT PRE-DILATED. TWO GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX DEVICE) DEVICES WERE IMPLANTED SUCCESSFULLY IN THE LRA. ON (B)(6) 2026, THE PHYSICIAN REPORTED THE PROXIMAL LRA WAS FOUND TO BE OCCLUDED. REPORTEDLY, THE LRA HAD A PRE-EXISTING MEDTRONIC ENDURANT STENT. THE VBX DEVICE HAD A V-SHAPE, AND ON IMAGING, IT APPEARED THE VBX STENT WAS CAUGHT ON AN ENDURANT STRUT DURING DEPLOYMENT, CAUSING THE ABNORMAL SHAPED OF THE VBX DEVICE. AS REPORTED, THERE HAS BEEN NO INTERVENTION PERFORMED.

    Patient problems: Reduced Blood Flow; Thrombosis/Thrombus

    MAUDE report 24722943 ↗
  • InjuryFeb 26, 2026Partial Blockage

    THE FOLLOWING INFORMATION WAS RECEIVED FROM CLINICAL COMPLAINT SPECIALIST. ON (B)(6) 2026, THE PATIENT UNDERWENT ENDOVASCULAR PROCEDURE TO TREAT A THORACOABDOMINAL AORTIC ANEURYSM USING A GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS (TAMBE) DEVICE SYSTEM. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX DEVICES) WERE IMPLANTED WITH THE TAMBE DEVICE. ON (B)(6) 2026, IT WAS REPORTED THAT THERE WAS CONCERN OF THROMBOSIS IN THE RENAL ARTERIES AS THE PATIENT WAS HAVING PAIN. ON (B)(6) 2026 A THROMBECTOMY WAS PERFORMED TO ADDRESS THE CONCERN OF THROMBOSIS IN THE RENAL ARTERIES. THE THROMBOSIS WAS RESOLVED WITHOUT SEQUELAE. THE PATIENT TOLERATED THE PROCEDURE.

    Patient problems: Thrombosis/Thrombus

    MAUDE report 24456921 ↗
  • InjuryFeb 24, 2026Device Dislodged or Dislocated

    ON (B)(6) 2025, A PATIENT WAS TREATED FOR A THORACOABDOMINAL AORTIC ANEURYSM EXTENDING INTO THE ILIAC ARTERIES. DURING THE PROCEDURE, A GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS WAS USED IN THE RIGHT INTERNAL ILIAC ARTERY. ON (B)(6) 2025, A ONE-MONTH FOLLOW-UP CT SCAN SHOWED A TYPE 1C ENDOLEAK IN THE RIGHT ILIAC ARTERY ANEURYSM SAC DUE TO POOR STENT APPOSITION WITHIN THE INTERNAL ILIAC ARTERY. CONTRAST WAS ALSO NOTED NEAR THE LEFT COMMON ILIAC ARTERY, BUT WAS BELIEVED TO BE FROM THE RIGHT SIDE ENDOLEAK. ON (B)(6) 2026, A REINTERVENTION TOOK PLACE TO PLACE AN ADDITIONAL STENT GRAFT. REPORTEDLY, THE REINTERVENTION SUCCESSFULLY CORRECTED THE ENDOLEAK.

    Patient problems: Clinical Endoleak

    MAUDE report 24435028 ↗
  • InjuryNov 4, 2025Activation Failure; Device Endoleak; Activation Failure; Device Endoleak

    THE FOLLOWING INFORMATION WAS REPORTED THROUGH THE AAA 24-01 TAMBE POST APPROVAL STUDY: ON (B)(6) 2025, THE PATIENT UNDERWENT ENDOVASCULAR PROCEDURE TO TREAT A PARARENAL AORTIC ANEURYSM USING A GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS (TAMBE) DEVICE SYSTEM. THE PATIENT TOLERATED THE PROCEDURE AND DISCHARGED HOME ON (B)(6) 2025. ON (B)(6) 2025, A COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) WAS DONE AND AN AORTIC ANEURYSM ENLARGEMENT OF 10MM WAS DETERMINED. ADDITIONALLY, ON (B)(6) 2025, AN ENDOLEAK OF AN UNKNOWN ETIOLOGY WAS DETERMINED. ACCORDING TO DR. (B)(6) THE ENDOLEAK CAUSED THE ANEURYSM ENLARGEMENT. THE SITE UPDATED THE STUDY DATA FOR: ON (B)(6) 2025, A TYPE II ENDOLEAK AND A TYPE IIIC ENDOLEAK WERE DETERMINED. THE PATIENT RECEIVED VASOACTIVE MEDICATIONS PENDING VASCULAR SURGERY CONSULT. ON (B)(6) 2025, THE ADDITIONAL PROCEDURE WAS DONE WHERE DR. (B)(6) DID THE FOLLOWING: STENTED THE SUPERIOR MESENTERIC AND RIGHT RENAL ARTERIES AS WELL AS RETROGRAFTED THE AORTIC SAC ACCESS WITH A STENTING OF RIGHT RENAL WITH GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX) DEVICE AND DID A COIL EMBOLIZATION ON THE INFERIOR MESENTERIC ARTERY (IMA) USING PENUMBRA RUBY COILS. THE

    Patient problems: Clinical Endoleak

    MAUDE report 23467269 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P160021. One submission often covers many models, so check the product and lot details in each record.

  • Z-0077-2022 · Sep 7, 2021 · Open, Classified
    Heparin, GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROTHESIS, REF BXAL085902E, 8 MM X 59 MM 8 Fr, LARGE BALLOON EXPANDLBE, Nominal Stent Diameter 8 mm, Max Post-Dilated Stent Diame

Other Iliac covered stent, arterial devices

All Iliac covered stent, arterial devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page